DK0975333T3 - Alginatgel med langvarig frigörelse - Google Patents

Alginatgel med langvarig frigörelse

Info

Publication number
DK0975333T3
DK0975333T3 DK98915592T DK98915592T DK0975333T3 DK 0975333 T3 DK0975333 T3 DK 0975333T3 DK 98915592 T DK98915592 T DK 98915592T DK 98915592 T DK98915592 T DK 98915592T DK 0975333 T3 DK0975333 T3 DK 0975333T3
Authority
DK
Denmark
Prior art keywords
alginate gel
prolonged release
release alginate
gel
prolonged
Prior art date
Application number
DK98915592T
Other languages
Danish (da)
English (en)
Inventor
Merrill Seymour Goldenberg
Alice C Beekman
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0975333T3 publication Critical patent/DK0975333T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
DK98915592T 1997-04-17 1998-04-14 Alginatgel med langvarig frigörelse DK0975333T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/842,756 US6656508B2 (en) 1997-04-17 1997-04-17 Sustained-release alginate gels
PCT/US1998/007566 WO1998046211A1 (en) 1997-04-17 1998-04-14 Sustained-release alginate gels

Publications (1)

Publication Number Publication Date
DK0975333T3 true DK0975333T3 (da) 2007-06-18

Family

ID=25288180

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98915592T DK0975333T3 (da) 1997-04-17 1998-04-14 Alginatgel med langvarig frigörelse

Country Status (13)

Country Link
US (1) US6656508B2 (ja)
EP (1) EP0975333B1 (ja)
JP (1) JP2001524084A (ja)
AT (1) ATE354351T1 (ja)
AU (1) AU6973498A (ja)
CA (1) CA2286092C (ja)
DE (1) DE69837140T2 (ja)
DK (1) DK0975333T3 (ja)
ES (1) ES2283052T3 (ja)
PT (1) PT975333E (ja)
TW (1) TW577755B (ja)
WO (1) WO1998046211A1 (ja)
ZA (1) ZA983089B (ja)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
AU2003200609B2 (en) * 1998-05-18 2006-02-23 Amgen Inc. Biodegradable sustained-release alginate gels
US6432449B1 (en) * 1998-05-18 2002-08-13 Amgen Inc. Biodegradable sustained-release alginate gels
ATE310531T1 (de) 1998-08-07 2005-12-15 Stabilisierte pharmazeutische zusammensetzungen von hedgehog-proteinen und deren verwendung
EP1127578A4 (en) * 1998-10-28 2004-12-15 Sankyo Co MEDICINE FOR BONE METABOLIC DEVIATIONS
DE60021059T2 (de) * 1999-02-03 2006-05-18 Powderject Research Ltd. Partikuläre pharmazeutische Zusammensetzung für eine transdermale Partikelabgabe aus einem nadellosen Spritzensystem
AU770235B2 (en) * 1999-03-08 2004-02-19 Powderject Research Limited Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
EP1541132A1 (en) * 2000-05-12 2005-06-15 Pharmacia & Upjohn Company LLC Vaccine composition, method of preparing the composition and method of vaccinating vertebrates
ES2243497T3 (es) 2000-05-12 2005-12-01 PHARMACIA & UPJOHN COMPANY LLC Composicion de vacuna, procedimiento de preparacion de la misma y procedimiento para vacunacion de vertebrados.
AU2002251831A1 (en) * 2001-01-30 2002-08-12 The Regents Of The University Of Michigan Methods for sustained release local delivery of drugs for ablation of unwanted tissue
EP1270015A3 (en) * 2001-06-29 2004-02-25 Sankyo Company Limited A complex comprising OCIF and Polysaccharide
JP2003081865A (ja) * 2001-09-12 2003-03-19 Ltt Institute Co Ltd 水不溶性徐放性組成物、その製剤及びその製造方法
US20040005999A1 (en) * 2002-03-07 2004-01-08 Andreasen Kasper Huus Polyamino acid-based particle insulin preparation
US6840196B2 (en) 2002-03-13 2005-01-11 Aspen Pet Products, Inc. Rawhide pet chew
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
US8112400B2 (en) * 2003-12-23 2012-02-07 Texas Instruments Incorporated Method for collecting data from semiconductor equipment
FI116625B (fi) * 2004-01-28 2006-01-13 Macrocrystal Oy Menetelmä proteiinien kiteyttämiseksi hiilihydraattirunkoisilla polymeereillä
EP1781282A4 (en) * 2004-07-23 2010-09-01 Dpi Solutions Inc COMPOSITION FOR STABILIZING VITAMIN C IN WATER PHASE AND THIS USE METHOD FOR STABILIZING VITAMIN C
CA2583308C (en) * 2004-10-08 2020-01-07 Georgia Tech Research Corporation Microencapsulation of cells in hydrogels using electrostatic potentials
BRPI0515973B8 (pt) 2004-10-12 2021-07-27 Fmc Biopolymer As kit para produzir um gel de alginato, composição para preparar um gel e uso
US20060099550A1 (en) 2004-11-10 2006-05-11 Ranir/Dcp Corporation Device and method for delivering an oral care agent
ES2384641T3 (es) 2005-07-14 2012-07-10 Lithera, Inc. Formulación lipolítica que potencia la liberación mantenida para el tratamiento localizado del tejido adiposo
US20070116680A1 (en) * 2005-11-18 2007-05-24 Rensselaer Polytechnic Institute Stem cells within gel microenvironments
TWI285100B (en) * 2005-12-27 2007-08-11 Ind Tech Res Inst Surface modification of polysaccharide, the modified polysaccharide, and method of culturing and recovery cells using the same
US20080138416A1 (en) * 2006-06-13 2008-06-12 Fmc Biopolymer As Method and systems for using biopolymer-based beads and hydrogels
JP2010506941A (ja) * 2006-10-17 2010-03-04 リセラ,インク. 甲状腺眼症の治療のための方法、組成物及び製剤
GB0624227D0 (en) * 2006-12-05 2007-01-10 Common Services Agency Protein purification
JP5162134B2 (ja) * 2007-01-22 2013-03-13 愛媛県 機能性材料の製造方法、機能性材料、シート状構造体、及び衛生製品
WO2008118387A2 (en) * 2007-03-23 2008-10-02 Wayne State University Erythrocyte atp-release modulators
AU2008296975B2 (en) * 2007-08-28 2014-07-24 Fmc Corporation Delayed self-gelling alginate systems and uses thereof
NZ583632A (en) 2007-11-16 2012-05-25 Univ Rockefeller Antibodies specific for the protofibril form of beta-amyloid protein
CN102438657A (zh) * 2009-03-26 2012-05-02 沃萨乌整形外科公司 鉴别定向药物递送组合物的潜在组分的方法
US9132084B2 (en) * 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
KR20120113267A (ko) * 2010-01-15 2012-10-12 리쎄라 인코오포레이티드 동결건조 케이크 제제
US20130184835A1 (en) 2010-07-09 2013-07-18 Board Of Regents Of The Unversity Of Texas System Biodegradable scaffolds
EA201270784A1 (ru) 2010-11-24 2013-04-30 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" Монотерапевтические композиции селективного липофильного и бета-агониста длительного действия и способы косметического лечения ожирения и контурного выпячивания
GB201120368D0 (en) 2011-11-24 2012-01-04 Sperm Vital As Methods for the preparation of hydrogels
CN103830266A (zh) * 2013-04-24 2014-06-04 杨亚勤 部分氧化海藻酸钠羧甲基化衍生物的制备方法和应用
US10383825B2 (en) 2015-08-13 2019-08-20 Temple University—Of the Commonwealth System of Higher Education Calcium alginate dosage formulations, and methods of making and using thereof
CA3013904C (en) 2016-02-10 2023-12-12 Rutgers, The State University Of New Jersey Novel anti-lam and anti-pim6/lam monoclonal antibodies for diagnosis and treatment of mycobacterium tuberculosis infections
KR102228440B1 (ko) 2016-04-13 2021-03-15 가부시키가이샤 엘에스아이 메디엔스 황산화 다당류를 이용한 면역학적 측정법
WO2018044970A1 (en) 2016-08-31 2018-03-08 University Of Rochester Human monoclonal antibodies to human endogenous retrovirus k envelope (herv-k) and uses thereof
WO2020045162A1 (ja) * 2018-08-30 2020-03-05 学校法人慶應義塾 薬物送達用担体

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2507193A (en) 1949-05-17 1950-05-09 Bristol Lab Inc Penicillin product
US2882203A (en) 1951-06-26 1959-04-14 Novo Terapeutisk Labor As Injectable insulin preparation with protracted effect
US2741573A (en) 1953-12-28 1956-04-10 Abbott Lab Penicillin compositions for intramuscular injection
US3676557A (en) 1971-03-02 1972-07-11 Endo Lab Long-acting narcotic antagonist formulations
JPS5416979B2 (ja) 1972-01-08 1979-06-26
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4400391A (en) * 1980-01-09 1983-08-23 The United States Of America As Represented By The Secretary Of Agriculture Controlled release of bioactive materials using alginate gel beads
US4789516A (en) 1983-04-15 1988-12-06 Damon Biotech, Inc Production of sustained released system
US4690682A (en) 1983-04-15 1987-09-01 Damon Biotech, Inc. Sustained release
US4744933A (en) 1984-02-15 1988-05-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system
CA1215922A (en) 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4695463A (en) 1985-05-24 1987-09-22 Warner-Lambert Company Delivery system for active ingredients and preparation thereof
GB2186485B (en) * 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
US4933185A (en) * 1986-09-24 1990-06-12 Massachusetts Institute Of Technology System for controlled release of biologically active compounds
AU5107490A (en) 1989-01-26 1990-08-24 Damon Biotech Inc. Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle
US5007790A (en) 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
US5175093A (en) * 1989-11-07 1992-12-29 Lehigh University Bioactive cells immobilized in alginate beads containing voids formed with polyethylene glycol
US5215758A (en) 1991-09-11 1993-06-01 Euroceltique, S.A. Controlled release matrix suppository for pharmaceuticals
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5837747A (en) * 1991-10-29 1998-11-17 Vivorx, Inc. Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
US5656297A (en) 1992-03-12 1997-08-12 Alkermes Controlled Therapeutics, Incorporated Modulated release from biocompatible polymers
US5711968A (en) 1994-07-25 1998-01-27 Alkermes Controlled Therapeutics, Inc. Composition and method for the controlled release of metal cation-stabilized interferon
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
NZ260909A (en) 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
US5451411A (en) * 1993-10-15 1995-09-19 University Of Washington Methods and compositions for the oral delivery of therapeutic agents
WO1996000081A1 (en) 1994-06-24 1996-01-04 Immunex Corporation Controlled release polypeptide compositions and methods of treating inflammatory bowel disease
US5629184A (en) 1995-01-25 1997-05-13 Amgen Inc. Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides
CA2224381A1 (en) 1995-06-27 1997-01-16 Takeda Chemical Industries, Ltd. Method of producing sustained-release preparation
EP0877627A1 (en) 1996-01-25 1998-11-18 Eli Lilly And Company Obesity protein analog compounds and formulations thereof
EP0889737A1 (en) 1996-02-06 1999-01-13 Eli Lilly And Company Obesity protein compounds and formulations thereof

Also Published As

Publication number Publication date
CA2286092C (en) 2004-12-14
DE69837140T2 (de) 2007-11-29
JP2001524084A (ja) 2001-11-27
ATE354351T1 (de) 2007-03-15
EP0975333B1 (en) 2007-02-21
EP0975333A1 (en) 2000-02-02
DE69837140D1 (de) 2007-04-05
AU6973498A (en) 1998-11-11
CA2286092A1 (en) 1998-10-22
ZA983089B (en) 1998-10-19
ES2283052T3 (es) 2007-10-16
PT975333E (pt) 2007-05-31
TW577755B (en) 2004-03-01
US6656508B2 (en) 2003-12-02
US20020001619A1 (en) 2002-01-03
WO1998046211A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
DK0975333T3 (da) Alginatgel med langvarig frigörelse
ATE343378T1 (de) Biologisch abbaubares alginatgel mit verzögerter freisetzung
YU58599A (sh) Gelovi sa usporenim podržanim oslobađanjem
ATE264863T1 (de) 28-epirapaloge
EE9800123A (et) Stabiilsed lüofiliseeritud ravimvormid
NO994727D0 (no) Bremsesystem
ID17860A (id) Komposisi vaksin
ATE203519T1 (de) Chinolinderivate als antimalariamittel
DE69601182T2 (de) Silicongelzusammensetzung
FI961128A0 (fi) Palonsammutuslaitteisto
NO20000107L (no) Ny blanding
DK0857474T3 (da) Bremse til kørestol
KR960036082U (ko) 목걸이
KR970042768U (ko) 터보 차저를 이용한 브레이크 냉각장치
NO971876L (no) Ny affinitetsgel
ATE226465T1 (de) Löschgerät
FI972988A0 (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
NO962452D0 (no) Tannbehandlingssystem
ATA113997A (de) Artikulator
KR980000326U (ko) 귀걸이
SE9500793D0 (sv) Snabblås
KR970060097U (ko) 프로젝션 티이 브이
KR970016594U (ko) 압정
SE9603201D0 (sv) Bromskraftsindikering
BR9605327A (pt) Microdispositivo eletroepidermico bionizador do ser humano